← Insulin × glycemic control

TrialCroatian medical journal2007

Effect of rosiglitazone and metformin on insulin resistance in patients infected with human immunodeficiency virus receiving highly active antiretroviral therapy containing protease inhibitor: randomized prospective controlled clinical trial.

Anja Silic et al.PubMed ↗Full text ↗Publisher ↗

The primary results report of NCT00483392.

What the trial testedas reported · 2007

No range given

Reported lower glycemic control, no range given

−0.95

As reported

difference −0.95, no interval

No range given

Reported lower glycemic control, no range given

−0.62

As reported

difference −0.62, no interval

Two numbers in the abstract

the abstract, start to end

… resistance from 11.3+/-1.03 to 4.0+/-0.95 (P<0.001), compared with metformin which reduced it from 11.9+/-0.73 to 5.7+/-0.62 (P<0.001).

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Glycemic control
−0.95
Glycemic control
−0.62
MetforminThiazolidinedionesInsulinGlycemic control
1 / 3

7 papers cite it

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
this paperpooled ittrialcites it

The trial

NCT00483392this paper is its primary report
Full record →Abstract, authors, funding and every citing paper · PMID 18074413